With EEA-Lex you can find information about proposed EU legal acts with possible EEA relevance, adopted EU acts under consideration for incorporation into the EEA Agreement, and acts that have already been incorporated into the Agreement.
Searching in English gives the widest results. You can refine your research results by using the categories in the right-hand column.
 |
Commission Implementing Decision concerning, in the framework of Article 31 of Directive 2001/83/EC of the European Parliament and of the Council, the marketing authorisations of medicinal products for human use which contain the active substance "methocarbamol/paracetamol 380 mg/300 mg"
|
|---|
|
|
Commission Implementing Decision of XXX concerning, in the framework of Article 31 of Directive 2001/83/EC of the European Parliament and of the Council, the marketing authorisations of fosfomycin-containing medicinal products for human use which contain one or more of the active substances "fosfomycin calcium, fosfomycin disodium, fosfomycin sodium and fosfomycin trometamol"
|
|---|
|
|
Commission Regulation .../... amending Regulation (EC) No 1881/2006 as regards maximum levels of acrylamide in certain foodstuffs for infants and young children
|
|---|
|
|
Commission Implementing Decision …/... concerning, in the framework of Article 107e of Directive 2001/83/EC of the European Parliament and of the Council, the marketing authorisations of medicinal products for human use which contain the active substance " midazolam (oromucosal solution, treatment of prolonged, acute, convulsive seizures)"
|
|---|
|
|
Commission Implementing Decision .../... partially granting an authorisation for certain uses of chromium trioxide under Regulation (EC) No 1907/2006 of the European Parliament and of the Council (REACHLaw Ltd)
|
|---|
|
|
Commission Implementing Decision .../... of XXX concerning, in the framework of Article 29 of Directive 2001/83/EC of the European Parliament and of the Council, the marketing authorisations for “Ibuprofen Kabi 400 mg Infusionslösung and associated names”, medicinal products for human use which contain the active substance “ibuprofen” "
|
|---|
|
|
Commission Implementing Decision .../... concerning, in the framework of Article 35 of Directive 2001/82/EC of the European Parliament and of the Council, the marketing authorisations for veterinary medicinal products containing stresnil 40 mg/ml solution for injection for pigs and associated names, and generic products thereof
|
|---|
|
|
Commission Implementing Decision of XXX concerning, in the framework of Article 35 of Directive 2001/82/EC of the European Parliament and of the Council, the marketing authorisations for veterinary medicinal products containing tiamulin hydrogen fumarate presented as premix for medicated feeding stuff and oral powder for in-feed use to be administered to pigs
|
|---|
|
|
Commission Implementing Decision .../... concerning, in the framework of Article 35 of Directive 2001/82/EC of the European Parliament and of the Council, the marketing authorisations for veterinary medicinal products “Valbazen 100 mg/ml Total Spectrum Wormer oral suspension and associated names, including its generic/hybrid products “ containing the active substance “Albendazole”
|
|---|
|
|
Commission Regulation (EU) …/… of XXX amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, acrinathrin, Bacillus pumilus QST 2808, chlorantraniliprole, ethirimol, lufenuron, penthiopyrad, picloram and Pseudomonas sp. strain DSMZ 13134 in or on certain products
|
|---|
|
|
Commission Implementing Regulation (EU) …/… of XXX amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for clethodim, dazomet, hexythiazox, metam and sethoxydim in or on certain products
|
|---|
|
|
Commission Implementing Decision .../... of XXX establishing a list of geographical indications protected under Regulation (EU) 2019/787 of the European Parliament and of the Council to be filed as applications for international registration pursuant to Article 2 of Regulation (EU) 2019/1753 of the European Parliament and of the Council
|
|---|
|
|
Commission Implementing Decision of XXX concerning the extension of the action taken by the Croatian Ministry of Health permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Article 55(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council
|
|---|
|
|
Commission Implementing Decision .../... concerning, in the framework of Article 35 of Directive 2001/82/EC of the European Parliament and of the Council, the marketing authorisations for veterinary medicinal products “Modified live porcine respiratory and reproductive syndrome (PRRS) virus vaccines“ containing “Porcine respiratory and reproductive syndrome virus vaccine (live)”
|
|---|
|
|
Commission Implementing Decision .../... of XXX granting an authorisation under Regulation (EC) No 1907/2006 of the European Parliament and of the Council to BioMarin International Limited for certain uses of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO)
|
|---|
|
|
Proposal for a Regulation of the European Parliament and of the Council laying down harmonised conditions for the marketing of construction products, amending Regulation (EU) 2019/1020 and repealing Regulation (EU) 305/2011
|
|---|
|
|
Proposal for a Regulation of the European Parliament and of the Council on prohibiting products made with forced labour on the Union market
|
|---|
|
|
Proposal for a Regulation of the European Parliament and of the Council on horizontal cybersecurity requirements for products with digital elements and amending Regulation (EU) 2019/1020
|
|---|
|
|
Proposal for a Regulation of the European Parliament and of the Council amending Regulations (EU) 2016/424, (EU) 2016/425, (EU) 2016/426, (EU) 2019/1009 and (EU) No 305/2011 as regards emergency procedures for the conformity assessment, adoption of common specifications and market surveillance due to a Single Market emergency
|
|---|
|
|
Proposal for a Directive of the European Parliament and of the Council amending Directives 2000/14/EC, 2006/42/EC, 2010/35/EU, 2013/29/EU, 2014/28/EU, 2014/29/EU, 2014/30/EU, 2014/31/EU, 2014/32/EU, 2014/33/EU, 2014/34/EU, 2014/35/EU, 2014/53/EU and 2014/68/EU as regard emergency procedures for the conformity assessment, adoption of common specifications and market surveillance due to a Single Market emergency
|
|---|
|
|
Proposal for a Regulation of the European Parliament and of the Council on the sustainable use of plant protection products and amending Regulation (EU) 2021/2115
|
|---|
|
|
Proposal for a Regulation of the European Parliament and of the Council on type-approval of motor vehicles and engines and of systems, components and separate technical units intended for such vehicles, with respect to their emissions and battery durability (Euro 7) and repealing Regulations (EC) No 715/2007 and (EC) No 595/2009
|
|---|
|
|
Proposal for a Regulation of the European Parliament and of the Council on packaging and packaging waste, amending Regulation (EU) 2019/1020 and Directive (EU) 2019/904, and repealing Directive 94/62/EC
|
|---|
|
|
Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures
|
|---|
|
|
Commission Implementing Regulation (EU) …/... of XXX granting a Union authorisation for the biocidal product family ‘CVAS Biocidal Product Family based on L (+) Lactic Acid’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
|
|---|
- 1 of 5
- next
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.